Uber raised its earnings forecast for its first quarter of 2022, citing a strong rebound in use as the omicron variant of the coronavirus subsides, CNBC reported March 7.
Previously it expected its earnings to sit between $100 million and $130 million, but, given its increase in business as COVID-19 cases decline, the company has adjusted its EBITDA to between $130 million and $150 million.
"Our mobility business is bouncing back from Omicron much faster than we expected,” said Dara Khosrowshahi, CEO in the SEC filing. "Whether for travel, commuting, or going out at night, we’re seeing healthy and growing demand across all use cases, highlighting just how eager consumers are to get moving again."
Uber's healthcare branch, Uber Health, has also been making moves as of late, continuing the tech transport giant's move into healthcare. This branch though was not mentioned in the filing.